Ascendis Pharma A/S (ASND)

Ascendis Pharma Revenue

In the year 2023, Ascendis Pharma had annual revenue of $296.35M with 444.36% growth. Revenue in the quarter ending December 31, 2023 was $153.00M with 528.15% year-over-year growth.

• Revenue (ttm): $296.35M
• Revenue Growth: +444.36%
• P/S Ratio: 26.94
• Revenue / Employee: $337,148
• Employees: 879
• Market Cap: 8.06B USD

Revenue Chart

* The company reports in EUR currency but revenue data is shown in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	296.35M	241.91M	444.36%
Dec 31, 2022	54.44M	45.60M	515.94%
Dec 31, 2021	8.84M	359.37K	4.24%
Dec 31, 2020	8.48M	-6.55M	-43.58%
Dec 31, 2019	15.03M	2.87M	23.57%
Dec 31, 2018	12.16M	10.33M	562.40%
Dec 31, 2017	1.84M	-3.01M	-62.12%
Dec 31, 2016	4.85M	-3.97M	-45.02%
Dec 31, 2015	8.82M	-8.10M	-47.89%
Dec 31, 2014	16.92M	-11.15M	-39.71%
Dec 31, 2013	28.06M	7.51M	36.53%
Dec 31, 2012	20.56M	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.